Back to Search Start Over

FDA approves once-monthly injectable for bipolar I disorder

Source :
Mental Health Weekly. August 21, 2017, Vol. 27 Issue 33, p3, 2 p.
Publication Year :
2017

Abstract

Pharmaceutical officials announced July 28 the U.S. Food and Drug Administration's (FDA's) approval of an extended-release injectable suspension for the maintenance monotherapy treatment of bipolar I disorder (BP-I) in adults. [...]

Subjects

Subjects :
United States. Food and Drug Administration
Antipsychotic agents
Medical research
Mania -- Drug therapy
Bipolar disorder -- Drug therapy
Drug approval
Law
Psychology and mental health
Abilify (Medication)

Details

Language :
English
ISSN :
10581103
Volume :
27
Issue :
33
Database :
Gale General OneFile
Journal :
Mental Health Weekly
Publication Type :
News
Accession number :
edsgcl.531576081

Tools

Authors Abstract Subjects Details